The improvements in liver function and steatosis in congenital and diet-induced obesity mouse models lacking Slc39a5, led us to investigate whether loss of Slc39a5 protects against NASH. Here, SLC39A5 is linked to metabolic dysfunction-associated steatohepatitis.